Treatment Action Group finds global funding for TB research rose by just 2% in 2010

24 March 2012 - New York - A report by the Treatment Action Group (TAG) and the Stop TB Partnership reveals that in 2010 the world invested just $630.4 million in TB research and development. While this is a two percent rise on 2009 figures, it is the smallest year-on-year increase documented by TAG. Research and development funding remains at less than one-third of the projected $2 billion annual investment needed to eliminate TB as a public health threat by the year 2050.

The report is the second edition of TAG’s 2011 research funding trends report. Updates to this report include new funding figures from the Canadian Institutes for Health Research, the Global Fund, as well as revised data from Pfizer and the European Commission.

"The report provides year-on-year trends for policymakers and activists so they may identify who the major TB donors are, know where the funds are invested, and determine where to target advocacy efforts,” said TAG’s senior researcher Eleonora Jiménez-Levi. “We hope it will catalyze donors, government, industry, and civil society to work toward the US$ 2 billion per year needed to produce new tools to prevent, diagnose, and treat TB."